Abstract No. 140: MRI of Intracoronary Local Agent Delivery Using Motexafin Gadolinium: Towards Molecular MRI-guided Gene Therapy
Y. Meng,J. Wang,J. Sun,F. Zhang,H. Wang,T. Zhang,B. Qiu,X. Yang
DOI: https://doi.org/10.1016/j.jvir.2011.12.183
IF: 3.682
2012-01-01
Journal of Vascular and Interventional Radiology
Abstract:PurposeTo develop a new technique, using molecular MRI to monitor local agent delivery to coronary artery walls for inhibiting in-stent restenosis.Materials and MethodsThis study was divided into two phases: ex vivo evaluation and in vivo validation. For the ex vivo evaluation, we placed a custom-made microporous delivery balloon catheter into the coronary arteries of three cadaveric pig hearts, which were placed in a saline-filled phantom. Axial spin echo T1-weighted MRI of heart was performed to display the coronary artery wall, with MR parameters of 500ms TR, 8ms TE and number of average=4. Then, we locally infused 2-ml Motexafin Gadolinium (MGd, Pharmacyclics, Inc.)/Trypan blue mixture into the coronary arterial wall under MRI. Axial spin echo T1-weighted MRI was performed again post-MGd/blue infusion. For the in vivo validation, we placed a 9F sheath in the carotid artery under ultrasound guidance. Through an 8F guiding catheter via the sheath, the custom microporous delivery balloon was placed into the left coronary arteries of two living pigs under fluoroscopy guidance. We then delivered 2-mL MGd/blue mixture into arterial walls under MRI, with parameters of 385ms TR, 21ms TE, 300×240mm FOV, 376×371 matrix, 5mm thickness, and number of average=2 with cardiac and respiratory triggers. MR contrast-to-noise ratios (CNR) of the coronary arterial walls were measured, and targeted coronary arteries were then harvested for MRI-histologic correlation.ResultsAxial T1-weighted MRI showed a significant enhancement of the coronary artery walls after the MGd/blue infusion in comparison to the control arterial walls or pre-MGd/blue infusion. The average CNR of coronary arterial walls was higher for post-MGd/blue infusion than pre-MGd/blue infusion. Histology detected trypan blue as blue-color deposits and MGd-emitted red fluorescent spots through the arterial walls, which were not seen in the control arterial walls.ConclusionThis study initially demonstrates the possibility of using MRI to monitor the local agent delivery and distribution in the coronary arterial walls, which establishes groundwork to explore a new technique, molecular MRI-guided intracoronary local gene therapy. PurposeTo develop a new technique, using molecular MRI to monitor local agent delivery to coronary artery walls for inhibiting in-stent restenosis. To develop a new technique, using molecular MRI to monitor local agent delivery to coronary artery walls for inhibiting in-stent restenosis. Materials and MethodsThis study was divided into two phases: ex vivo evaluation and in vivo validation. For the ex vivo evaluation, we placed a custom-made microporous delivery balloon catheter into the coronary arteries of three cadaveric pig hearts, which were placed in a saline-filled phantom. Axial spin echo T1-weighted MRI of heart was performed to display the coronary artery wall, with MR parameters of 500ms TR, 8ms TE and number of average=4. Then, we locally infused 2-ml Motexafin Gadolinium (MGd, Pharmacyclics, Inc.)/Trypan blue mixture into the coronary arterial wall under MRI. Axial spin echo T1-weighted MRI was performed again post-MGd/blue infusion. For the in vivo validation, we placed a 9F sheath in the carotid artery under ultrasound guidance. Through an 8F guiding catheter via the sheath, the custom microporous delivery balloon was placed into the left coronary arteries of two living pigs under fluoroscopy guidance. We then delivered 2-mL MGd/blue mixture into arterial walls under MRI, with parameters of 385ms TR, 21ms TE, 300×240mm FOV, 376×371 matrix, 5mm thickness, and number of average=2 with cardiac and respiratory triggers. MR contrast-to-noise ratios (CNR) of the coronary arterial walls were measured, and targeted coronary arteries were then harvested for MRI-histologic correlation. This study was divided into two phases: ex vivo evaluation and in vivo validation. For the ex vivo evaluation, we placed a custom-made microporous delivery balloon catheter into the coronary arteries of three cadaveric pig hearts, which were placed in a saline-filled phantom. Axial spin echo T1-weighted MRI of heart was performed to display the coronary artery wall, with MR parameters of 500ms TR, 8ms TE and number of average=4. Then, we locally infused 2-ml Motexafin Gadolinium (MGd, Pharmacyclics, Inc.)/Trypan blue mixture into the coronary arterial wall under MRI. Axial spin echo T1-weighted MRI was performed again post-MGd/blue infusion. For the in vivo validation, we placed a 9F sheath in the carotid artery under ultrasound guidance. Through an 8F guiding catheter via the sheath, the custom microporous delivery balloon was placed into the left coronary arteries of two living pigs under fluoroscopy guidance. We then delivered 2-mL MGd/blue mixture into arterial walls under MRI, with parameters of 385ms TR, 21ms TE, 300×240mm FOV, 376×371 matrix, 5mm thickness, and number of average=2 with cardiac and respiratory triggers. MR contrast-to-noise ratios (CNR) of the coronary arterial walls were measured, and targeted coronary arteries were then harvested for MRI-histologic correlation. ResultsAxial T1-weighted MRI showed a significant enhancement of the coronary artery walls after the MGd/blue infusion in comparison to the control arterial walls or pre-MGd/blue infusion. The average CNR of coronary arterial walls was higher for post-MGd/blue infusion than pre-MGd/blue infusion. Histology detected trypan blue as blue-color deposits and MGd-emitted red fluorescent spots through the arterial walls, which were not seen in the control arterial walls. Axial T1-weighted MRI showed a significant enhancement of the coronary artery walls after the MGd/blue infusion in comparison to the control arterial walls or pre-MGd/blue infusion. The average CNR of coronary arterial walls was higher for post-MGd/blue infusion than pre-MGd/blue infusion. Histology detected trypan blue as blue-color deposits and MGd-emitted red fluorescent spots through the arterial walls, which were not seen in the control arterial walls. ConclusionThis study initially demonstrates the possibility of using MRI to monitor the local agent delivery and distribution in the coronary arterial walls, which establishes groundwork to explore a new technique, molecular MRI-guided intracoronary local gene therapy. This study initially demonstrates the possibility of using MRI to monitor the local agent delivery and distribution in the coronary arterial walls, which establishes groundwork to explore a new technique, molecular MRI-guided intracoronary local gene therapy.